TY - JOUR
T1 - Following young people with perinatal HIV infection from adolescence into adulthood
T2 - The protocol for PHACS AMP Up, a prospective cohort study
AU - for the Pediatric HIV/AIDS Cohort Study
AU - Tassiopoulos, Katherine
AU - Patel, Kunjal
AU - Alperen, Julie
AU - Kacanek, Deborah
AU - Ellis, Angela
AU - Berman, Claire
AU - Allison, Susannah M.
AU - Hazra, Rohan
AU - Barr, Emily
AU - Cantos, Krystal
AU - Siminski, Suzanne
AU - Massagli, Michael
AU - Bauermeister, Jose
AU - Siddiqui, Danish Q.
AU - Puga, Ana
AU - Van Dyke, Russell
AU - Seage, George R.
N1 - Publisher Copyright:
© Published by the BMJ Publishing Group Limited.
PY - 2016/6/1
Y1 - 2016/6/1
N2 - Introduction The first generation of adolescents born with HIV infection has reached young adulthood due to advances in treatment. It is important to continue follow-up of these individuals to assess their long-term medical, behavioural and mental health and ability to successfully transition to adulthood while coping with a chronic, potentially stigmatising condition. To accomplish this, and to maintain their interest in long-term research participation, we need to accommodate the changing lifestyles and interests of young adult study participants while ensuring valid data collection. We report the protocol for Pediatric HIV/AIDS Cohort Study (PHACS) Adolescent Master Protocol (AMP) Up, a prospective cohort study enrolling young adult participants for long-term follow-up. Methods and analysis AMP Up is recruiting 850 young men and women 18â €...years of age and older - 600 perinatally HIV-infected and a comparison group of 250 perinatally HIV-exposed, uninfected - at 14 clinical research sites in the USA and Puerto Rico. Recruitment began in April 2014 and is ongoing, with 305 participants currently enrolled. Planned follow-up is ≥6â €...years. Data are collected with a flexible hybrid of online and in-person methods. Outcomes include: transition to adult clinical care and retention in care; end-organ diseases; malignancies; metabolic complications; sexually transmitted infections; reproductive health; mental health and neurocognitive functioning; adherence to antiretroviral treatment; sexual behaviour and substance use; hearing and language impairments; and employment and educational achievement. Ethics and dissemination The study received ethical approval from the Harvard T.H. Chan School of Public Health's institutional review board (IRB), and from the IRBs of each clinical research site. All participants provide written informed consent; for cognitively impaired individuals with legally authorised representatives, legal guardian permission and participant assent is obtained. Findings will be disseminated through peer-reviewed journals, conference presentations and participant summaries.
AB - Introduction The first generation of adolescents born with HIV infection has reached young adulthood due to advances in treatment. It is important to continue follow-up of these individuals to assess their long-term medical, behavioural and mental health and ability to successfully transition to adulthood while coping with a chronic, potentially stigmatising condition. To accomplish this, and to maintain their interest in long-term research participation, we need to accommodate the changing lifestyles and interests of young adult study participants while ensuring valid data collection. We report the protocol for Pediatric HIV/AIDS Cohort Study (PHACS) Adolescent Master Protocol (AMP) Up, a prospective cohort study enrolling young adult participants for long-term follow-up. Methods and analysis AMP Up is recruiting 850 young men and women 18â €...years of age and older - 600 perinatally HIV-infected and a comparison group of 250 perinatally HIV-exposed, uninfected - at 14 clinical research sites in the USA and Puerto Rico. Recruitment began in April 2014 and is ongoing, with 305 participants currently enrolled. Planned follow-up is ≥6â €...years. Data are collected with a flexible hybrid of online and in-person methods. Outcomes include: transition to adult clinical care and retention in care; end-organ diseases; malignancies; metabolic complications; sexually transmitted infections; reproductive health; mental health and neurocognitive functioning; adherence to antiretroviral treatment; sexual behaviour and substance use; hearing and language impairments; and employment and educational achievement. Ethics and dissemination The study received ethical approval from the Harvard T.H. Chan School of Public Health's institutional review board (IRB), and from the IRBs of each clinical research site. All participants provide written informed consent; for cognitively impaired individuals with legally authorised representatives, legal guardian permission and participant assent is obtained. Findings will be disseminated through peer-reviewed journals, conference presentations and participant summaries.
KW - EPIDEMIOLOGY
KW - PUBLIC HEALTH
UR - https://www.scopus.com/pages/publications/84974849201
U2 - 10.1136/bmjopen-2016-011396
DO - 10.1136/bmjopen-2016-011396
M3 - Article
C2 - 27288383
AN - SCOPUS:84974849201
SN - 2044-6055
VL - 6
JO - BMJ Open
JF - BMJ Open
IS - 6
M1 - e011396
ER -